ID
24166
Descrição
Study ID: 100576 (Y11) Clinical Study ID: 100576 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Tracking Document, Long Term Follow-up
Palavras-chave
Versões (1)
- 27/07/2017 27/07/2017 -
Transferido a
27 de julho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC-SA 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Serious Long Term Follow-up 100576
Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100576
Similar models
Long Term Follow-up Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100576
C2242969 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,2])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C2348568 (UMLS CUI [2,1])
C1517942 (UMLS CUI [2,2])
C0170300 (UMLS CUI [2,3])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
Sem comentários